News

Professor Kelly-Anne Phillips
General newsResearch

Clearer picture of cancer risk for women with BRCA1 or BRCA2 gene mutations

June 21, 2017
A study which tracked almost 10,000 women with BRCA1 or BRCA2 gene mutations for up to 20 years has provided the clearest picture yet of the long-term breast and ovarian cancer risks for women who have inherited an abnormality in these cancer-risk genes.
Read more
Professor Mark Dawson
General newsResearch

Scientists open new window on how drugs work in the body

June 16, 2017
Research led by Peter Mac has found a way to map, in unprecedented detail, all of a drug’s clinically important interactions in the body. The new tools can reveal how a small-molecule drug works at the cellular or genetic level, providing scientists with powerful new insights into what drives or - importantly - limits its anti-cancer effect.
Read more
Researchers from Peter Mac and the Walter and Eliza Hall Institute
General newsResearch

New treatment hope for women with BRCA1 breast cancers

June 8, 2017
Australian researchers have found a new way to use immunotherapy, a breakthrough mode of cancer treatment which harnesses the patient’s immune system, to treat an aggressive form of breast cancer. The researchers at Peter MacCallum Cancer Centre and Walter and Eliza Hall Institute have shown, for the first time, that combining two immunotherapy drugs could be effective in treating triple negative breast cancers arising in women with BRCA1 mutations.
Read more
Professor Miles Prince
General newsClinical research & trials

New drug works longer and for more patients with rare cancer

June 7, 2017
An Australian-led trial has shown a new drug works in almost five times as many patients, and has more durable benefits, compared to standard therapy for a rare skin-related cancer. The multi-centre Phase 3 clinical trial involved patients with cutaneous T-cell lymphoma, a cancer which causes debilitating and worsening skin problems and for which there is no known cure.
Read more
Joint Peter Mac, The Women's and Royal Melbourne Hospital Sorry Day event
General news

Parkville partners join to acknowledge National Sorry Day

May 26, 2017
The Women’s, the Royal Melbourne and the Peter MacCallum Cancer Centre held a combined event today to acknowledge National Sorry Day and affirm our joint commitment to righting the wrongs of the past and continuing along the journey of reconciliation.
Read more
Clinical trials participant John Mailes and Peter Mac's Professor Grant McArthur
Patient & carer storiesClinical research & trials

John’s story and a thank you to our trial participants

May 19, 2017
Clinical trials give our researchers and clinicians crucial evidence about the effect of new or experimental cancer treatments to guide our advances in cancer care. For patients like John Mailes, diagnosed in 2001 with a rare cancer which at that time had no effective treatment, a clinical trial can also deliver a new lease on life.
Read more
Dr Steven David
General newsClinical research & trials

Peter Mac partners to provide intra-operative radiation therapy via international trial

May 11, 2017
Peter Mac and Monash Health are working together as part of an international trial to provide single-dose radiation therapy to woman at the same time they undergo surgery for breast cancer. The trial of intra-operative radiation therapy (IORT) allows women to receive their required radiation dose in less than ten minutes, in a procedure that occurs during surgery to remove their tumour.
Read more
Professor Mark Dawson
General newsResearch

International Research Scholarship for Prof Mark Dawson

May 10, 2017
Peter Mac's Professor Mark Dawson has been selected as a Howard Hughes Medical Institute (HHMI) International Research Scholar. The scholarship recognises Prof Dawson as a leading early-career scientist working outside of the G7 group of countries.
Read more
Peter Mac Cup 2017
Media releasesPatient & carer stories

Peter Mac Cup kicking goals for cancer research, awareness for 25 years

May 3, 2017
This weekend two of the AFL’s greatest rivals, Carlton and Collingwood, will face off at the MCG for the Peter Mac Cup - the league’s longest running charity match now in its 25th year.
Read more
Mark and Sarah Jane Dawson Liquid biopsy
General newsMedia releasesResearch

World-first liquid biopsy for blood cancers promises less invasive, more precise and effective treatments

March 17, 2017
12,000+ Australians diagnosed with blood cancers each year could soon have access to a simple blood test to monitor their disease thanks to a world-first ‘liquid biopsy’ developed at Peter MacCallum Cancer Centre.
Read more